Morphine Hydrochloride
Morphine Hydrochloride - Related Videos
07:23
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
0 Views •
Cited by 41 •
2014
We describe a protocol to examine the development of opioid-induced hyperalgesia and tolerance in mice. Based on the measurement of thermal and mechanical nociceptive responses of naïve and morphine-treated animals, it allows to quantify the increase in pain sensitivity (hyperalgesia) and decrease in analgesia (tolerance) associated with chronic opiate administration.
01:20
Opioid Analgesics: Morphine and Other Natural Cogeners
0 Views •
2024
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
08:35
A Simple and Inexpensive Method for Determining Cold Sensitivity and Adaptation in Mice
0 Views •
Cited by 30 •
2015
The Cold Plantar Assay (CPA) measures cold responsiveness between 30 °C and 5 °C, and can also measure cold adaptation. This protocol describes how to use the CPA to measure cold hypersensitivity, analgesia, and adaptation in mice.
08:06
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
0 Views •
Cited by 57 •
2010
Parkinson disease is caused by loss of dopaminergic innervation to the striatum, which can be experimentally induced by 6-OH-dopamine. We describe how to perform a stereotaxic lesion and to monitor apomorphine-induced rotational behavior in mice. This model is useful and reliable for testing new therapies for Parkinson disease.
06:59
A Reverse Genetic Approach to Test Functional Redundancy During Embryogenesis
0 Views •
Cited by 6 •
2010
Gene function can be obscured in loss-of-function experiments if there is compensation by another gene. The zebrafish model provides a relatively high-throughput means to reveal such functional redundancy in living embryos.
FAQs
At μ-opioid receptors, morphine hydrochloride initiates signaling that lowers adenylate cyclase activity. This intracellular change contributes to reduced neuronal responsiveness to nociceptive input, helping explain analgesic effects. The receptor action also provides a mechanistic basis for examining how opioid signaling modifies behavior beyond pain, including arousal and reward-related responses.
Two linked changes help explain how receptor activation influences neuronal communication. By limiting calcium-dependent neurotransmitter release, the signal reduces the amount of transmitter released from affected neurons. Increased potassium conductance further changes membrane excitability. Together, these cellular effects can suppress nociceptive signaling while also altering neural circuits that support locomotion, arousal, respiration, or stress-related behavior.
A behavioral change after administration cannot automatically be interpreted as analgesia. Morphine hydrochloride can influence locomotion, reward, arousal, respiration, and stress-related responses in addition to nociceptive signaling. Consequently, studies of pain-related behavior benefit from considering these parallel effects, so reduced responding is interpreted within the broader behavioral profile rather than as a single-purpose outcome.
By acting on opioid receptors, the drug can influence circuits involved in more than pain processing. Changes in reward, learning, arousal, and stress-related responses make opioid signaling relevant to behavioral neuroscience. Studying these outcomes alongside analgesia helps researchers examine how a single pharmacological manipulation can produce distinct effects across behavioral domains.
Behavioral studies generally administer morphine hydrochloride in controlled experiments and examine responses afterward. The measured domain can include nociception, locomotion, reward, arousal, respiration, or stress-related behavior. This design allows investigators to relate a defined opioid-signaling manipulation to observable behavioral outcomes and to compare therapeutic analgesia with broader effects.
It supports controlled investigations of analgesia, tolerance, dependence, withdrawal, and opioid-related learning. These questions extend beyond whether nociceptive responses are reduced: they examine how opioid exposure relates to adaptation, withdrawal-related behavior, and learned responses. In this way, the compound serves as a tool for connecting opioid signaling with changes in behavior over time.
Within behavior research, morphine hydrochloride links molecular opioid actions with observable behavioral phenotypes. Findings from analgesia and non-analgesic measures can help clarify therapeutic effects while also informing studies of substance-use disorders. Its value lies in examining both desired pain-related outcomes and accompanying changes in reward, arousal, stress, or learning.